Horejsí J
Cas Lek Cesk. 1989 Feb 10;128(7):193-7.
The paper informs on the present state of preparation of a vaccine against infection with the hepatitis B virus, using techniques of genetic engineering. Synthesis of immunogenic peptides derived from the structure of HBaAg amino acids stimulated the administration of several oligopeptides derived from the structure of HBsAg. Experiments with the decapeptide derived from the S-portion of HBsAg revealed that also a small peptide, when administered with adjuvants, is immunogenic, Synthesis of HBsAg protein in a culture of Saccharomyces cerevisiae was already tested clinically and proved to be an effective vaccine. It will be probably also possible to prepare the vaccine by formation of the anti-idiotype, induced by HBsAg anti Ig. The authors' own observation revealed that the administration of anti HBsAg immunoglobulin (Hepaga) causes in rabbits the formation of a component which reacts in serum by the RIA technique as HBsAg.
本文介绍了利用基因工程技术制备抗乙型肝炎病毒感染疫苗的现状。从乙肝表面抗原(HBsAg)氨基酸结构衍生的免疫原性肽的合成促使了几种源自HBsAg结构的寡肽的应用。对源自HBsAg S区的十肽进行的实验表明,当与佐剂一起给药时,一种小肽也具有免疫原性。在酿酒酵母培养物中合成HBsAg蛋白已经进行了临床测试,并被证明是一种有效的疫苗。通过由HBsAg抗Ig诱导形成抗独特型来制备疫苗可能也是可行的。作者自己的观察结果表明,给兔子注射抗HBsAg免疫球蛋白(Hepaga)会使其血清中形成一种成分,该成分通过放射免疫分析(RIA)技术检测时反应如同HBsAg。